Cargando…

Endoscopic ultrasound-guided through-the-needle microforceps biopsy improves diagnostic yield for pancreatic cystic lesions: a systematic review and meta-analysis

Background and study aims  Given variable diagnostic yield of endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA) for pancreatic cystic lesions (PCLs), a through-the-needle (TTN) microforceps biopsy device passed through a 19-gauge FNA needle has been devised to improve tissue sampling....

Descripción completa

Detalles Bibliográficos
Autores principales: McCarty, Thomas, Rustagi, Tarun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508652/
https://www.ncbi.nlm.nih.gov/pubmed/33015329
http://dx.doi.org/10.1055/a-1194-4085
_version_ 1783585455336325120
author McCarty, Thomas
Rustagi, Tarun
author_facet McCarty, Thomas
Rustagi, Tarun
author_sort McCarty, Thomas
collection PubMed
description Background and study aims  Given variable diagnostic yield of endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA) for pancreatic cystic lesions (PCLs), a through-the-needle (TTN) microforceps biopsy device passed through a 19-gauge FNA needle has been devised to improve tissue sampling. This was a systematic review and meta-analysis to evaluate the feasibility, diagnostic yield, and safety of EUS-guided TTN microforceps biopsy for diagnosis of PCLs. Methods  Individualized searches were developed in accordance with PRISMA and MOOSE guidelines. This was a cumulative meta-analysis performed by calculating pooled proportions with rates estimated using random effects models. Measured outcomes included pooled technical success, diagnostic yield, accuracy, and procedure-associated adverse events (AEs) as well as comparison to conventional FNA. Results  Eleven studies (n = 518 patients; mean age 64.13 ± 5.83 years; 58.19 % female) were included. Mean PCL size was 33.39 ± 3.72 mm with the pancreatic head/uncinate (35.50 %) being the most common location. A mean of 2.47 ± 0.92 forceps passes were performed with a mean of 2.79 ± 0.81 microbiopsies obtained per lesion. Pooled technical success was 97.12 % (95 % CI, 93.73–98.71; I (2)  = 34.49) with a diagnostic yield of 79.60 % (95 % CI, 72.62–85.16; I (2)  = 56.00), and accuracy of 82.76 % [(95 % CI, 77.80–86.80; I (2)  = 0.00). The pooled serious adverse event rate was 1.08 % (95 % CI, 0.43–2.69; I (2)  = 0.00). Compared to conventional FNA, TTN microforceps biopsy resulted in significant improvement in diagnostic yield [OR 4.79 (95 % CI: 1.52–15.06; P  = 0.007)] and diagnostic accuracy [OR 8.69 (95 % CI, 1.12–67.12; P  = 0.038)], respectively. Conclusions  EUS-guided TTN microforceps biopsy appears to be safe and effective for diagnosis of PCLs with improvement in diagnostic yield and accuracy when compared to FNA alone.
format Online
Article
Text
id pubmed-7508652
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-75086522020-10-01 Endoscopic ultrasound-guided through-the-needle microforceps biopsy improves diagnostic yield for pancreatic cystic lesions: a systematic review and meta-analysis McCarty, Thomas Rustagi, Tarun Endosc Int Open Background and study aims  Given variable diagnostic yield of endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA) for pancreatic cystic lesions (PCLs), a through-the-needle (TTN) microforceps biopsy device passed through a 19-gauge FNA needle has been devised to improve tissue sampling. This was a systematic review and meta-analysis to evaluate the feasibility, diagnostic yield, and safety of EUS-guided TTN microforceps biopsy for diagnosis of PCLs. Methods  Individualized searches were developed in accordance with PRISMA and MOOSE guidelines. This was a cumulative meta-analysis performed by calculating pooled proportions with rates estimated using random effects models. Measured outcomes included pooled technical success, diagnostic yield, accuracy, and procedure-associated adverse events (AEs) as well as comparison to conventional FNA. Results  Eleven studies (n = 518 patients; mean age 64.13 ± 5.83 years; 58.19 % female) were included. Mean PCL size was 33.39 ± 3.72 mm with the pancreatic head/uncinate (35.50 %) being the most common location. A mean of 2.47 ± 0.92 forceps passes were performed with a mean of 2.79 ± 0.81 microbiopsies obtained per lesion. Pooled technical success was 97.12 % (95 % CI, 93.73–98.71; I (2)  = 34.49) with a diagnostic yield of 79.60 % (95 % CI, 72.62–85.16; I (2)  = 56.00), and accuracy of 82.76 % [(95 % CI, 77.80–86.80; I (2)  = 0.00). The pooled serious adverse event rate was 1.08 % (95 % CI, 0.43–2.69; I (2)  = 0.00). Compared to conventional FNA, TTN microforceps biopsy resulted in significant improvement in diagnostic yield [OR 4.79 (95 % CI: 1.52–15.06; P  = 0.007)] and diagnostic accuracy [OR 8.69 (95 % CI, 1.12–67.12; P  = 0.038)], respectively. Conclusions  EUS-guided TTN microforceps biopsy appears to be safe and effective for diagnosis of PCLs with improvement in diagnostic yield and accuracy when compared to FNA alone. Georg Thieme Verlag KG 2020-10 2020-09-22 /pmc/articles/PMC7508652/ /pubmed/33015329 http://dx.doi.org/10.1055/a-1194-4085 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle McCarty, Thomas
Rustagi, Tarun
Endoscopic ultrasound-guided through-the-needle microforceps biopsy improves diagnostic yield for pancreatic cystic lesions: a systematic review and meta-analysis
title Endoscopic ultrasound-guided through-the-needle microforceps biopsy improves diagnostic yield for pancreatic cystic lesions: a systematic review and meta-analysis
title_full Endoscopic ultrasound-guided through-the-needle microforceps biopsy improves diagnostic yield for pancreatic cystic lesions: a systematic review and meta-analysis
title_fullStr Endoscopic ultrasound-guided through-the-needle microforceps biopsy improves diagnostic yield for pancreatic cystic lesions: a systematic review and meta-analysis
title_full_unstemmed Endoscopic ultrasound-guided through-the-needle microforceps biopsy improves diagnostic yield for pancreatic cystic lesions: a systematic review and meta-analysis
title_short Endoscopic ultrasound-guided through-the-needle microforceps biopsy improves diagnostic yield for pancreatic cystic lesions: a systematic review and meta-analysis
title_sort endoscopic ultrasound-guided through-the-needle microforceps biopsy improves diagnostic yield for pancreatic cystic lesions: a systematic review and meta-analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508652/
https://www.ncbi.nlm.nih.gov/pubmed/33015329
http://dx.doi.org/10.1055/a-1194-4085
work_keys_str_mv AT mccartythomas endoscopicultrasoundguidedthroughtheneedlemicroforcepsbiopsyimprovesdiagnosticyieldforpancreaticcysticlesionsasystematicreviewandmetaanalysis
AT rustagitarun endoscopicultrasoundguidedthroughtheneedlemicroforcepsbiopsyimprovesdiagnosticyieldforpancreaticcysticlesionsasystematicreviewandmetaanalysis